Star Health Reports 25% Profit Growth in Q1 Under Ind AS Accounting Framework

What Happened

Star Health Insurance Limited, one of India's leading standalone health insurance providers, announced consolidated Q1 FY2024–25 results with a PAT of ₹550 crore, marking a 25% growth compared to ₹440 crore in the same quarter of the previous financial year. The results were reported under Indian Accounting Standards (Ind AS), the mandatory accounting framework applicable to insurance companies regulated by the Insurance Regulatory and Development Authority of India (IRDAI).

The insurer's Q1 performance reflects both operational gains and the accounting treatment methodology under Ind AS, which differs materially from the previous statutory accounting norms. The transition to Ind AS has created important distinctions in how insurance entities recognise revenue, measure liabilities, and present financial performance — distinctions that directly affect reported profitability and balance sheet composition.

Star Health's gross premium income, combined ratio, and investment returns all contributed to the bottom-line growth. However, the explicit reference to Ind AS in the earnings announcement indicates the company is flagging the accounting framework as material context for stakeholder interpretation of results.

Why It Matters

The mandatory adoption of Ind AS across the insurance sector (effective from April 2018) represents a fundamental shift in financial reporting architecture. For insurance entities, Ind AS introduces volatility in reported earnings through mark-to-market treatment of investments, different revenue recognition patterns, and revised measurement of insurance liabilities using fulfilment cash flows rather than statutory reserve bases.

This 25% profit growth is particularly noteworthy because it must be read in the context of Ind AS mechanics, not legacy statutory accounting. Under Ind AS 17 (Insurance Contracts, later superseded by IFRS 17 principles), actuarial assumptions around discount rates, lapse rates, and expense bases can materially influence reported profitability. Investment portfolio volatility flows through the P&L more transparently than under statutory reserves, where smoothing mechanisms historically dampened earnings swings.

For finance professionals and compliance teams, the distinction is critical: Ind AS reported profits cannot be directly compared to pre-Ind AS historical baselines without adjustment. The insurance regulator (IRDAI) requires statutory solvency reporting on a parallel basis, creating a dual-reporting obligation where regulated capital adequacy is measured separately from reported financial statements.

Star Health's explicit highlighting of Ind AS in its earnings release signals awareness that investors, analysts, and stakeholders need clarity on the accounting framework context. This is prudent disclosure practice and reflects CA standards around transparent presentation of financial results.

Practical Impact

For CFOs and finance teams at insurance entities, Star Health's Q1 results reinforce the importance of maintaining dual P&L narratives: one under Ind AS for statutory financial statements and consolidated reporting, and one under statutory solvency basis for regulator submissions and capital adequacy computation. A 25% reported profit growth does not automatically translate to 25% improvement in solvency margins or distributable reserves, as statutory bases often operate on different measurement principles.

Audit and compliance professionals must ensure that Q1 results are reconciled between Ind AS presentation and IRDAI-prescribed statutory formats. The Reserve Bank of India (RBI) has also strengthened expectations around liability adequacy testing and fair value disclosures; insurance auditors must verify that investment portfolio revaluations are properly captured and disclosed in accordance with both Ind AS and IRDAI circulars.

For tax compliance purposes, insurance entities also need to monitor the interaction between Ind AS reported profits and taxable income under the Income Tax Act. The IT Act does not fully align with Ind AS measurement principles — provisions, reserve movements, and investment gains may be treated differently for income tax computation, requiring careful reconciliation schedules.

Investors and rating agencies will likely scrutinise Star Health's combined ratio (loss ratio plus expense ratio), investment yield, and new business growth alongside the reported PAT. A 25% profit increase is material, but sustainability depends on whether it reflects operational leverage, improved claims experience, or mark-to-market gains on investments — each with different implications for forward earnings quality.

Insurance entities regulated by IRDAI must also ensure that dividend policies, reserve adequacy certifications, and statutory disclosures are framed with reference to both Ind AS profit and statutory solvency surplus, avoiding confusion in stakeholder communications.

Key Takeaways

• →Star Health's 25% Q1 profit growth is reported under Ind AS; direct comparison to historical results requires adjustment for accounting framework changes introduced from April 2018
• →Insurance entities face dual-reporting obligations: Ind AS for financial statements and statutory bases for IRDAI solvency and capital adequacy — audit and compliance teams must reconcile both
• →Investment portfolio volatility, actuarial assumption changes, and liability measurement under Ind AS create earnings volatility not present under legacy statutory reserves; context is essential for analyst interpretation
• →Tax compliance professionals must separately compute taxable income from Ind AS reported profit, as the Income Tax Act does not align with Ind AS measurement principles on provisions, reserves, and gains
• →CFOs should maintain transparent dual-narrative disclosures and ensure dividend policies and solvency certifications reference both Ind AS profit and statutory surplus to avoid stakeholder misinterpretation

Disclaimer: This update is for general information only and does not constitute legal, tax or professional advice. Regulatory positions may change. Please consult APRA & Associates LLP for advice specific to your business. Contact us.